GSK3B and polycystic kidney disease: Moreover, GSK-3β has a novel functional role in polycystic kidney disease (PKD) pathophysiology, and its inhibition may be therapeutically useful to slow down cyst expansion and progression of PKD (Tao et al., 2015).